Commission Delegated Regulation (EU) 2020/1737 of 14 July 2020 amending Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005 as regards the inclusion of certain drug precursors in the list of scheduled substances (Text with EEA relevance)
Corrected by
  • Corrigendum to Commission Delegated Regulation (EU) 2020/1737 of 14 July 2020 amending Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005 as regards the inclusion of certain drug precursors in the list of scheduled substances, 32020R1737R(03), August 5, 2021
Commission Delegated Regulation (EU) 2020/1737of 14 July 2020amending Regulation (EC) No 273/2004 of the European Parliament and of the Council and Council Regulation (EC) No 111/2005 as regards the inclusion of certain drug precursors in the list of scheduled substances(Text with EEA relevance)
Article 1Amendments to Regulation (EC) No 273/2004Annexes I and II to Regulation (EC) No 273/2004 are amended in accordance with Annex I to this Regulation.
Article 2Amendments to Regulation (EC) No 111/2005The Annex to Regulation (EC) No 111/2005 is amended in accordance with Annex II to this Regulation.
Article 3Entry into force and applicationThis Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.Point (1)(b) and point (2) of Annex I and point (2)(b) of Annex II shall apply from 13 January 2021.
This Regulation shall be binding in its entirety and directly applicable in all Member States.ANNEX IAnnexes I and II to Regulation (EC) No 273/2004 are amended as follows:(1)Annex I is amended as follows:(a)the table "CATEGORY 1" is amended as follows:(i)the entry for Alpha-phenylacetoacetonitrile is replaced by the following:
SubstanceCN designation (if different)CN CodeCAS No
"Alpha-phenylacetoacetonitrile (APAAN)292640004468-48-8"
(ii)in the entry for (1R,2S)-(-)-chloroephedrine, the CN code "29399900" is replaced by "29397990";(iii)in the entry for (1S,2R)-(+)-chloroephedrine, the CN code "29399900" is replaced by "29397990";(iv)in the entry for (1S,2S)-(+)-chloropseudoephedrine, the CN code "29399900" is replaced by "29397990";(v)in the entry for (1R,2R)-(-)-chloropseudoephedrine, the CN code "29399900" is replaced by "29397990";(vi)the following entries are inserted in the appropriate place sequentially according to the CN Code:
SubstanceCN designation (if different)CN CodeCAS No
"Methyl 3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylate (PMK methyl glycidate)2932990013605-48-6
3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylic acid (PMK glycidic acid)293299002167189-50-4
Alpha-phenylacetoacetamide (APAA)292429704433-77-6
Methyl 2-methyl-3-phenyloxirane-2-carboxylate(BMK methyl glycidate)2918999080532-66-7
2-methyl-3-phenyloxirane-2-carboxylic acid(BMK glycidic acid)2918999025547-51-7
Methyl alpha-phenylacetoacetate (MAPA)2918300016648-44-5"
(b)in the table "SUBCATEGORY 2A", the following entry is inserted in the appropriate place sequentially according to the CN Code:
SubstanceCN designation (if different)CN CodeCAS No.
"Red phosphorus280470007723-14-0"
(c)in the entry for Anthranilic acid in the table "SUBCATEGORY 2B", the CN code "29224300" is replaced by "29224300";(d)in the entry for Sulphuric acid in the table "CATEGORY 3", the CN code "28070010" is replaced by "28070000";(2)in the table in Annex II, the following entry is added:
SubstanceThreshold
"Red phosphorus0,1 kg"
ANNEX IIThe Annex to Regulation (EC) No 111/2005 is amended as follows:(1)the table "CATEGORY 1" is amended as follows:(a)the entry for Alpha-phenylacetoacetonitrile is replaced by the following:
SubstanceCN designation (if different)CN CodeCAS No
"Alpha-phenylacetoacetonitrile (APAAN)292640004468-48-8"
(b)in the entry for (1R,2S)-(-)-chloroephedrine, the CN code "29399900" is replaced by "29397990";(c)in the entry for (1S,2R)-(+)-chloroephedrine, the CN code "29399900" is replaced by "29397990";(d)in the entry for (1S,2S)-(+)-chloropseudoephedrine, the CN code "29399900" is replaced by "29397990";(e)in the entry for (1R,2R)-(-)-chloropseudoephedrine, the CN code "29399900" is replaced by "29397990";(f)the following entries are inserted in the appropriate place sequentially according to the CN Code:
SubstanceCN designation (if different)CN CodeCAS No
"Methyl 3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylate (PMK methyl glycidate)2932990013605-48-6
3-(1,3-benzodioxol-5-yl)-2-methyloxirane-2-carboxylic acid (PMK glycidic acid)293299002167189-50-4
Alpha-phenylacetoacetamide (APAA)292429704433-77-6
Methyl 2-methyl-3-phenyloxirane-2-carboxylate(BMK methyl glycidate)2918999080532-66-7
2-methyl-3-phenyloxirane-2-carboxylic acid(BMK glycidic acid)2918999025547-51-7
Methyl alpha-phenylacetoacetate (MAPA)2918300016648-44-5"
(2)the table "Category 2" is amended as follows:(a)in the entry for Anthranilic acid in, the CN code "29224300" is replaced by "29224300";(b)the following entry is inserted in the appropriate place sequentially according to the CN Code:
SubstanceCN designation (if different)CN CodeCAS No.
"Red phosphorus280470007723-14-0"
(3)in the entry for Sulphuric acid in the table "Category 3", the CN code "28070010" is replaced by "28070000";(4)the table "Category 4" is amended as follows:(a)in the entry for medicinal products and veterinary medicinal products containing ephedrine or its salts, the CN code "3003 40 20" is replaced by "30034100" and the CN code "3004 40 20" is replaced by "30044100";(b)in the entry for medicinal products and veterinary medicinal products containing pseudoephedrine or its salts, the CN code "3003 40 30" is replaced by "30034200" and the CN code "3004 40 30" is replaced by "30044200".
Loading ...